Wegovy Batches Withdrawn Upon Discovery of Hair in a Pre-Filled Syringe

Certain batches of Wegovy are being pulled from circulation because hair has been detected in pre-filled syringes. This action ensures patient safety and highlights the importance of quality control in pharmaceutical products. Consumers are advised to check for affected lots.

Information here is not meant to replace expert medical guidance, diagnosis, or therapy. Always avoid ignoring professional medical advice or postponing its pursuit based on what you've encountered here. Do not depend on these details as a substitute for consulting a healthcare provider. We do not suggest or support any particular examinations, items, processes, views, or other data that might be included. Refer to extra details.

Source Information

Originally published by www.theepochtimes.com.Read the original article →

Keep exploring

More on Wegovy

Articles covering Wegovy dosing, side effects, and clinical updates.

Health & Wellness

What's the Deal with Peptides? The Hyped Market Under FDA Review

An in-depth look at the FDA's review of unregulated peptide therapy, the safety concerns raised by experts, and the conflict between industry demand and clinical evidence.

8 min read

Health & Wellness

Eli Lilly, Novo Nordisk Address Awareness Gap for Medicare’s $50 GLP-1 Program

Learn how the new Medicare GLP-1 Bridge program works, which drugs are covered, and why major pharmaceutical companies are leading the awareness push for the $50 copay initiative.

8 min read

Medical Research

Eli Lilly's Retatrutide Shows Cardiovascular and Diabetic Benefits in Trials

Eli Lilly's investigational drug, retatrutide, has shown promising results in clinical trials, offering substantial weight loss and significant improvements in cardiovascular health and type 2 diabetes management.

7 min read

Same topic: Drug Recall

All Drug Recall articles →

GLP-1 Medications

Wegovy Recall: Hair in Syringes, Gold Star Droppings Issue

Novo Nordisk recalled Wegovy pens after FDA inspectors found hair particles in prefilled syringes. Gold Star Distribution issued a broad recall due to rodent feces and droppings in storage. These Class II recalls highlight contamination risks in GLP-1 medications and pharma supply chains.

3 min read

Health

Are Replicas of Ozempic and Wegovy Safe? Understanding Compounded GLP-1s

Compounded semaglutide medications are custom-made by compounding pharmacies, containing the active ingredient in Ozempic and Wegovy. However, they are not FDA-approved and carry potential risks. This article explains what you need to know about these alternatives.

12 min read

More in Health

Health

Fat Jabs Slash Alcohol-Related Hospitalisations by More Than a Quarter

Recent analysis indicates that GLP-1 weight loss medications significantly reduce the risk of alcohol-related hospital admissions by approximately 26 percent compared to other diabetes treatments.

8 min read

Health

Doctors Warn a New GLP-1 Finding May Raise Your Risk of Smell Loss

Researchers analyzed nearly 877,000 patients and found a significant link between GLP-1 receptor agonists and sensory disturbances.

8 min read

Health

Wegovy Pill in New Jersey Stores: Where to Obtain It

The new Wegovy GLP-1 pill for weight loss is now accessible in New Jersey stores. With growing interest in these medications, this guide covers availability, pricing, and key safety information. Health tracking apps like Shotlee can assist in monitoring progress during use.

2 min read